Free Thyroxine (fT4) as a Potential Biomarker of Neurological and Functional Outcome in Acquired Brain Injury: A Prospective Multicenter Cohort Study.

acquired brain injury biomarker outcome rehabilitation thyroid hormones

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
30 Nov 2023
Historique:
received: 17 10 2023
revised: 20 11 2023
accepted: 27 11 2023
medline: 9 12 2023
pubmed: 9 12 2023
entrez: 9 12 2023
Statut: epublish

Résumé

The potential involvement of thyroid hormones (THs) in the neurological and functional recovery of patients with brain damage has been hypothesized. We aimed at investigating the role of THs and their variations during the rehabilitation process as predictive biomarkers of neurological and functional outcome in patients with acquired brain injury (ABI). This prospective, multicenter cohort study included 220 patients with ABI consecutively admitted for a 6-month neurorehabilitation program. Data on the etiology of the brain injury, occurrence of seizures, neurosurgical procedures, and death during hospitalization were collected. Both at the baseline (T0) and at the end of the rehabilitation process (T1), the following variables were evaluated: thyroid function (TSH, fT4, and fT3) and outcome measure including the Glasgow Coma Scale (GCS), Glasgow Outcome Scale-Extended (GOS-E), and Functional Independence Measure (FIM) scale. During neurorehabilitation, a significant decrease in fT4 levels was documented in the population as a whole and in patients with severe ABI (

Identifiants

pubmed: 38068485
pii: jcm12237433
doi: 10.3390/jcm12237433
pmc: PMC10707629
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

J Endocrinol Invest. 2022 Feb;45(2):379-389
pubmed: 34351610
Mol Cell Endocrinol. 2017 Sep 5;452:120-130
pubmed: 28549992
Front Endocrinol (Lausanne). 2014 Apr 28;5:62
pubmed: 24808891
Med Hypotheses. 2011 Oct;77(4):536-40
pubmed: 21737204
Aust J Physiother. 2009;55(1):65
pubmed: 19226247
Endocrinology. 1999 Sep;140(9):4221-7
pubmed: 10465295
Endocrinology. 2002 Jun;143(6):2242-9
pubmed: 12021188
Endocr Rev. 2019 Aug 1;40(4):1000-1047
pubmed: 31033998
Neurochem Res. 2008 Mar;33(3):569-78
pubmed: 17940896
Curr Top Dev Biol. 2017;125:303-335
pubmed: 28527576
Neuroscience. 2002;110(1):19-28
pubmed: 11882369
Neuroreport. 2002 Oct 28;13(15):1849-51
pubmed: 12395077
Curr Neurol Neurosci Rep. 2019 May 27;19(7):37
pubmed: 31134438
J Neurol Neurosurg Psychiatry. 2008 Jul;79(7):774-7
pubmed: 17991703
Drugs Aging. 2001;18(9):685-716
pubmed: 11599635
Front Endocrinol (Lausanne). 2022 Jul 07;13:887701
pubmed: 35872992
J Mol Endocrinol. 2010 Jan;44(1):13-23
pubmed: 19578096
Lancet. 1974 Jul 13;2(7872):81-4
pubmed: 4136544
Endocrinology. 2006 May;147(5):2567-74
pubmed: 16469804
J Endocrinol Invest. 2021 Aug;44(8):1597-1607
pubmed: 33320308
Lancet Glob Health. 2013 Nov;1(5):e259-81
pubmed: 25104492
Front Cell Neurosci. 2013 Jun 18;7:89
pubmed: 23785313
Int J Mol Sci. 2021 Mar 07;22(5):
pubmed: 33799967
Front Neurol. 2022 Nov 11;13:1060008
pubmed: 36438966
Thyroid. 1997 Feb;7(1):147-51
pubmed: 9086583
Neuropsychol Rehabil. 2018 Sep;28(6):879-898
pubmed: 27454928
Nat Rev Neurol. 2010 Jul;6(7):393-403
pubmed: 20551947
Exp Neurol. 2015 Jan;263:235-43
pubmed: 25447937
Seizure. 2015 Sep;31:155-64
pubmed: 26362394
Neuroscience. 2010 Jun 30;168(2):573-89
pubmed: 20338226
J Neurotrauma. 1998 Aug;15(8):573-85
pubmed: 9726257
BMC Neurosci. 2010 Apr 23;11:50
pubmed: 20412599
Front Neurol. 2019 Oct 18;10:1103
pubmed: 31681160
Epilepsy Behav. 2021 Aug;121(Pt B):106935
pubmed: 32035792
Semin Neurol. 2018 Apr;38(2):208-211
pubmed: 29791947
Pharmacol Ther. 2018 Jun;186:176-185
pubmed: 29378220
J Cereb Blood Flow Metab. 2005 Jun;25(6):673-84
pubmed: 15716856
J Biol Chem. 1990 Oct 25;265(30):18546-53
pubmed: 2170415
Neurobiol Dis. 2019 Mar;123:20-26
pubmed: 30030025
Arch Phys Med Rehabil. 1994 Feb;75(2):127-32
pubmed: 8311667
Front Endocrinol (Lausanne). 2014 Mar 31;5:40
pubmed: 24744751
Brain. 2019 Jul 1;142(7):e39
pubmed: 31145451
Epilepsia. 2014 Apr;55(4):475-82
pubmed: 24730690
Arch Phys Med Rehabil. 1993 Jun;74(6):566-73
pubmed: 8503745
Curr Opin Endocrinol Diabetes Obes. 2013 Oct;20(5):478-84
pubmed: 23974778
Lancet Neurol. 2019 May;18(5):459-480
pubmed: 30879893
J Head Trauma Rehabil. 2015 Nov-Dec;30(6):E47-53
pubmed: 25699617
Acta Neurochir (Wien). 2015 Oct;157(10):1683-96
pubmed: 26269030
Endocrinology. 2009 Aug;150(8):3953-9
pubmed: 19389834
J Clin Pharm Ther. 2020 Aug;45(4):759-766
pubmed: 32406070

Auteurs

Chiara Mele (C)

Department of Clinical-Surgical, Diagnostic and Pediatric Sciences, University of Pavia, 27100 Pavia, Italy.

Sergio Bagnato (S)

Unit of Neurophysiology and Unit for Severe Acquired Brain Injuries, Rehabilitation Department, Giuseppe Giglio Foundation, 90015 Cefalù, Italy.

Antonio De Tanti (A)

Cardinal Ferrari Centre, Santo Stefano Riabilitazione KOS-CARE, 43012 Fontanellato, Italy.

Lucia Francesca Lucca (LF)

S. Anna Institute, 88900 Crotone, Italy.

Donatella Saviola (D)

Cardinal Ferrari Centre, Santo Stefano Riabilitazione KOS-CARE, 43012 Fontanellato, Italy.

Laura Marcuccio (L)

Istituti Clinici Scientifici Maugeri IRCCS, Neurorehabilitation Unit of Telese Terme Institute, 82037 Telese Terme, Italy.

Pasquale Moretta (P)

Istituti Clinici Scientifici Maugeri IRCCS, Neurorehabilitation Unit of Telese Terme Institute, 82037 Telese Terme, Italy.

Federico Scarponi (F)

Department of Rehabilitation, San Giovanni Battista Hospital, 06034 Foligno, Italy.

Ernesto Losavio (E)

Istituti Clinici Scientifici Maugeri IRCCS, Neurorehabilitation and Spinal Unit of Bari Institute, 70124 Bari, Italy.

Emilia Picciola (E)

Istituti Clinici Scientifici Maugeri IRCCS, Neurorehabilitation and Spinal Unit of Bari Institute, 70124 Bari, Italy.

Valeria Pingue (V)

Istituti Clinici Scientifici Maugeri IRCCS, Neurorehabilitation and Spinal Unit of Pavia Institute, 27100 Pavia, Italy.

Classifications MeSH